SEARCH RESULTS FOR: "Tag: AXGT"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2019(2)
CATEGORIES
Analyst Update(1)
Buzz Stocks(1)
Jefferies Calls Bottom on Gene Therapy Stock After Huge Sell-Off
https://www.schaeffersresearch.com/content/news/2019/06/12/jefferies-calls-bottom-on-gene-therapy-stock-after-huge-sell-off
6/12/2019 10:30 AM
Axovant Sciences Ltd (NASDAQ:AXGT) has seen its stock fall from the mid-$30 range to yesterday's close of $3.94, even after positive data for its Parkinson's treatment. However, Jefferies referred to...
Penny Stock Pops on Parkinson's Treatment Progress
https://www.schaeffersresearch.com/content/news/2019/03/11/penny-stock-pops-on-parkinsons-treatment-progress
3/11/2019 9:43 AM
The shares of biotechnology concern Axovant Sciences Ltd (NASDAQ:AXGT) are up 54% at $2.28 in early trading after announcing successful phase 2 trial results for its Parkinson's treatment, AXO-Lenti...
PEOPLE ALSO SEARCH FOR
AXGT
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.
More About
Schaeffer's
Contact
Us
Partner Center